Hermed Capital

Investment Strategy - investing for medical advancement in China

Investment Area

Hermed Capital Fund has a clearly defined investment focus primarily on three healthcare subsectors, especially the growth capital in the sectors.

Pharmaceuticals Medical Device & Diagnostic Medical Service
  • · Chemical :Oncology, Cardiovascular, gastrointestinal, second generation drugs for blockbuster, brand generics, OTC, drug delivery platforms, CRO/CMO, etc.
  • · Biotech : Biosimilar, Vaccines, blood product, etc.
  • · Traditional Chinese Medicine(TCM)
  • · High-end devices, Consumables, Implantable Devices and Interventional Devices with high-technical barrier
  • · Medical IT : Medical Data Center Infrastructure Management (DCIM), and mobile device
  • · Molecular Diagnostics, immunological Diagnostics, Genetic Diagnostic
  • · Healthcare call centers, cell therapy, stem cell application, new therapy
  • · Hemodialysis Center, online services pharmacy
  • · Medical insurance
  • · Hospital Service: specialty hospitals, special dental clinics, day care center, nursing Home, infertility clinics, e-hospitals
  • · AI

Investment Approach

A clear and suitable approach is applied to create value.

  • “Value Identification”

    Investment
    Origination
  • Investment
    Screening
  • “Value Creation”

    Investment
    Execution
  • Post
    Investment
    Management
  • “Value Realization”

    Exit
    Strategy